Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Ischemic Heart Disease

  Free Subscription


01.06.2026

1 Am Heart J
3 Am J Cardiol
1 Am J Med
1 Angiology
1 Ann Thorac Surg
2 Circ Cardiovasc Interv
5 Circulation
2 Crit Care Med
7 J Am Coll Cardiol
2 JAMA
1 N Engl J Med
2 Prog Cardiovasc Dis
1 Thromb Haemost


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. STEG PG, Goodman SG, Jukema JW, Martens P, et al
    Design of VICTORION-2 Prevent: a randomized double-blind, placebo-controlled trial, assessing the impact of inclisiran on major adverse cardiovascular events in patients with established cardiovascular disease.
    Am Heart J. 2026 May 26:107493. doi: 10.1016/j.ahj.2026.107493.
    PubMed         Abstract available


    Am J Cardiol

  2. ALEXANDROU M, Vichos T, Carvalho PEP, Strepkos D, et al
    Safety and Effectiveness of Saphenous Vein Graft Use for Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention.
    Am J Cardiol. 2026 May 28:S0002-9149(26)00368.
    PubMed         Abstract available

  3. RIENAS W
    Next Steps and Barriers for Integration of Artificial Intelligence into Electronic Medical Records and Cardiovascular Health.
    Am J Cardiol. 2026 May 28:S0002-9149(26)00363.
    PubMed        

  4. LIU R, Zheng W, Qin H, Zhou Y, et al
    Machine Learning-Based Peri-Procedural Prediction Model for No-Reflow Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome.
    Am J Cardiol. 2026 May 27:S0002-9149(26)00367.
    PubMed         Abstract available


    Am J Med

  5. AVRAHAMI D, Zahger D, Arbel R, Rokach L, et al
    Effect of Cumulative Blood Pressure Exposure on Long-Term Cardiovascular Outcomes in the Community, a Nationwide Cohort Study.
    Am J Med. 2026 May 21:S0002-9343(26)00430-4. doi: 10.1016/j.amjmed.2026.
    PubMed         Abstract available


    Angiology

  6. GUNES MT
    Letter: Re: Association Between Anemia and Prognosis in Patients With Acute Coronary Syndrome and Atrial Fibrillation.
    Angiology. 2026 May 26:33197261456790. doi: 10.1177/00033197261456790.
    PubMed        


    Ann Thorac Surg

  7. LI Z, Larson HBSc J, Vervoort D, Rakhshan HBSc S, et al
    Bayesian reanalysis of revascularization strategies for left main disease: coronary artery bypass grafting versus percutaneous intervention.
    Ann Thorac Surg. 2026 May 26:S0003-4975(26)00478.
    PubMed         Abstract available


    Circ Cardiovasc Interv

  8. ZHOU J, Chen Z, Li C
    Response to Letter Regarding Article, "Interpreting AI noise Driven Radiation Reduction in Coronary Angiography: The Role of Technical and Clinical Determinants".
    Circ Cardiovasc Interv. 2026 May 28:e016971.
    PubMed        

  9. PEDABALLE KS
    Letter by Pedaballe Regarding Article, "Ultra-Low-Dose Noise-Free Technology to Reduce Radiation Exposure During Coronary Angiography".
    Circ Cardiovasc Interv. 2026 May 28:e016950.
    PubMed        


    Circulation

  10. BARNES GD, Lech T, Allen AL
    Anticoagulation Services as a Model for Cardiovascular Medication Stewardship.
    Circulation. 2026;153:1603-1605.
    PubMed        

  11. FERREIRA ZIMMER C, Marquard JM, Jabbari R, Sabbah M, et al
    Impact of Angina on Outcome After Percutaneous Coronary Intervention in Patients Undergoing Transcatheter Aortic Valve Implantation: Insights From the NOTION-3 Trial.
    Circulation. 2026;153:1687-1690.
    PubMed        

  12. LIU K, Yao K
    Letter by Liu and Yao Regarding Article, "Phenotypic Selectivity of Artificial Intelligence-Enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction".
    Circulation. 2026;153:e1340-e1341.
    PubMed        

  13. CROON PM, Khera R
    Response by Croon and Khera to Letter Regarding Article, "Phenotypic Selectivity of Artificial Intelligence-Enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction".
    Circulation. 2026;153:e1342-e1343.
    PubMed        

  14. MONGUILLON V, Marston NA, Bohula EA, Park JG, et al
    Lipoprotein(a) Levels, Risk of Cardiovascular Events and Benefit of Evolocumab: Findings From the VESALIUS-CV Trial.
    Circulation. 2026 May 25. doi: 10.1161/CIRCULATIONAHA.126.080999.
    PubMed         Abstract available


    Crit Care Med

  15. CHOTALIA M, Ali M, Chotalia R, Patel JM, et al
    Cardiovascular Subphenotypes in Sepsis.
    Crit Care Med. 2026 May 25. doi: 10.1097/CCM.0000000000007159.
    PubMed         Abstract available

  16. COOPER HA, Fordyce CB, Herbert BM, Alexander JH, et al
    Red Cell Transfusion in Critically Ill and Noncritically Ill Patients With Acute Myocardial Infarction and Anemia-A Subanalysis of the Myocardial Ischemia and Transfusion (MINT) Trial.
    Crit Care Med. 2026 May 25. doi: 10.1097/CCM.0000000000007211.
    PubMed         Abstract available


    J Am Coll Cardiol

  17. YAO Z, Dardari ZA, LaMonte MJ, Matsushita K, et al
    The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes: The Cross Cohort Collaboration (CCC).
    J Am Coll Cardiol. 2026 May 27:S0735-1097(26)06222.
    PubMed         Abstract available

  18. AL-KINDI S, Ayers MP, Ayuba G, Cavender MA, et al
    Roadmap to Revitalizing Academic Cardiovascular Medicine: A Perspective From the Association of Professors of Cardiology (APC) Emerging Leaders Group.
    J Am Coll Cardiol. 2026 May 27:S0735-1097(26)06210.
    PubMed         Abstract available

  19. PETEK BJ, Ajufo E, Churchill TW, Guseh JS, et al
    Cardiovascular Risk Prediction Across the Spectrum of Measured Physical Activity.
    J Am Coll Cardiol. 2026 May 17:S0735-1097(26)06271.
    PubMed        

  20. MEIN SA, Khadke S, Ganatra S
    Air Pollution and Cardiovascular Health: Turning Evidence Into Action.
    J Am Coll Cardiol. 2026;87:2843-2845.
    PubMed        

  21. LIU M, He Y
    Visual Acuity: A Pragmatic Marker Bridging Cardiovascular Risk, Traditional Factors, and Biological Aging.
    J Am Coll Cardiol. 2026;87:2824-2825.
    PubMed        

  22. KRUMHOLZ HM
    The Male Survival Disadvantage: A Cardiovascular and Metabolic Puzzle.
    J Am Coll Cardiol. 2026;87:2761-2763.
    PubMed        

  23. RAY KK, Clarke N, Thornton P, Miles AE, et al
    Anti-inflammatory effects of oral NLRP3 inhibition with ruvonoflast among individuals at elevated cardiovascular risk.
    J Am Coll Cardiol. 2026 May 26:S0735-1097(26)06570.
    PubMed         Abstract available


    JAMA

  24. MORELLI N, Marotti C, Gallerini S
    Tenecteplase for Acute Non-Large Vessel Occlusion After Ischemic Stroke.
    JAMA. 2026 May 27. doi: 10.1001/jama.2026.4816.
    PubMed        

  25. MA G, Zhong L, Hao J
    Tenecteplase for Acute Non-Large Vessel Occlusion After Ischemic Stroke-Reply.
    JAMA. 2026 May 27. doi: 10.1001/jama.2026.4819.
    PubMed        


    N Engl J Med

  26. BIOLA H, Davis J, Khan SS, Lloyd-Jones D, et al
    Cardiovascular Risk Factors - Lifestyle Modifications.
    N Engl J Med. 2026;394:e44.
    PubMed        


    Prog Cardiovasc Dis

  27. MARKOUSIS-MAVROGENIS G, Ebrahimihoor E, Lima JAC, Weber B, et al
    Coronary artery Ectatic/Aneurysmatic disease: From pathophysiology to management.
    Prog Cardiovasc Dis. 2026 May 23:S0033-0620(26)00044.
    PubMed         Abstract available

  28. MCPARLAND J, Rikhi R, Bhatia HS, Razavi AC, et al
    Comparative associations of LDL-C, Lp(a), hsCRP, and IL-6 with cardiovascular risk: Insights from the United Kingdom (UK) biobank and the multi-ethnic study of atherosclerosis (MESA).
    Prog Cardiovasc Dis. 2026 May 22:S0033-0620(26)00046.
    PubMed         Abstract available


    Thromb Haemost

  29. MAURO MS, Finocchiaro S, Calderone D, Laudani C, et al
    Bleeding and Thrombotic Trade-off in Dual-Risk Patients Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2026 May 29. doi: 10.1055/a-2862-6563.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum